Actually, the Danish economy was a lot more interesting (read more complex and diverse) a decade or two decades ago. Lots of mid-sized engineering companies, for instance. The government is rightly worried about things becoming a Novo Nordisk monoculture, becoming fragile, and ending up like Finland. Novo Nordisk is facing tough competition from Eli Lilly and many other pharmas, who have better GLP-1 drugs but were slower in their development.
